Article
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
25 Jan 2024
Abstract excerpt
Small cell lung cancer (SCLC) is an aggressive malignancy composed of distinct transcriptional subtypes, but implementing subtyping in the clinic has remained challenging, particularly due to limited tissue availability. Given the known epigenetic regulation of critical SCLC transcriptional programs, we hypothesized that subtype-specific patterns of DNA methylation could be detected in tumor or blood from SCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
